Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe.

Karim Fizazi; Per-Anders Abrahamsson; Göran Ahlgren; Joaquim Bellmunt; Daniel Castellano; Stephane Culine; Ronald de Wit; Silke Gillessen; Juergen E Gschwend; Freddie Hamdy; Nicholas James; Raymond McDermott; Kurt Miller; Thomas Wiegel; Manfred Wirth; Bertrand Tombal

doi:10.1016/j.eururo.2014.08.076

Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe.

Karim Fizazi, Per-Anders Abrahamsson, Göran Ahlgren, Joaquim Bellmunt, Daniel Castellano, Stephane Culine, Ronald de Wit, Silke Gillessen, Juergen E Gschwend, Freddie Hamdy, Nicholas James, Raymond McDermott, Kurt Miller, Thomas Wiegel, Manfred Wirth, Bertrand Tombal

Urological cancer, Malmö

Research output: Contribution to journal › Review article › peer-review

Abstract

Phase 3 trials have made major contributions to advances in prostate cancer (PCa). However, funding limitations and excess bureaucracy are now making it difficult to conduct trials.

Original language	English
Pages (from-to)	904-912
Journal	European Urology
Volume	67
Issue number	5
DOIs	https://doi.org/10.1016/j.eururo.2014.08.076
Publication status	Published - 2015

Subject classification (UKÄ)

Urology and Nephrology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.eururo.2014.08.076

http://www.ncbi.nlm.nih.gov/pubmed/25218582?dopt=Abstract

Cite this

Fizazi, K., Abrahamsson, P.-A., Ahlgren, G., Bellmunt, J., Castellano, D., Culine, S., de Wit, R., Gillessen, S., Gschwend, J. E., Hamdy, F., James, N., McDermott, R., Miller, K., Wiegel, T., Wirth, M., & Tombal, B. (2015). Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe. European Urology, 67(5), 904-912. https://doi.org/10.1016/j.eururo.2014.08.076

@article{6b9468aa6a2b455ebea5d39786ad836e,

title = "Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe.",

abstract = "Phase 3 trials have made major contributions to advances in prostate cancer (PCa). However, funding limitations and excess bureaucracy are now making it difficult to conduct trials.",

author = "Karim Fizazi and Per-Anders Abrahamsson and G{\"o}ran Ahlgren and Joaquim Bellmunt and Daniel Castellano and Stephane Culine and {de Wit}, Ronald and Silke Gillessen and Gschwend, {Juergen E} and Freddie Hamdy and Nicholas James and Raymond McDermott and Kurt Miller and Thomas Wiegel and Manfred Wirth and Bertrand Tombal",

year = "2015",

doi = "10.1016/j.eururo.2014.08.076",

language = "English",

volume = "67",

pages = "904--912",

journal = "European Urology",

issn = "1873-7560",

publisher = "Elsevier",

number = "5",

}

Fizazi, K, Abrahamsson, P-A, Ahlgren, G, Bellmunt, J, Castellano, D, Culine, S, de Wit, R, Gillessen, S, Gschwend, JE, Hamdy, F, James, N, McDermott, R, Miller, K, Wiegel, T, Wirth, M & Tombal, B 2015, 'Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe.', European Urology, vol. 67, no. 5, pp. 904-912. https://doi.org/10.1016/j.eururo.2014.08.076

TY - JOUR

T1 - Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe.

AU - Fizazi, Karim

AU - Abrahamsson, Per-Anders

AU - Ahlgren, Göran

AU - Bellmunt, Joaquim

AU - Castellano, Daniel

AU - Culine, Stephane

AU - de Wit, Ronald

AU - Gillessen, Silke

AU - Gschwend, Juergen E

AU - Hamdy, Freddie

AU - James, Nicholas

AU - McDermott, Raymond

AU - Miller, Kurt

AU - Wiegel, Thomas

AU - Wirth, Manfred

AU - Tombal, Bertrand

PY - 2015

Y1 - 2015

N2 - Phase 3 trials have made major contributions to advances in prostate cancer (PCa). However, funding limitations and excess bureaucracy are now making it difficult to conduct trials.

AB - Phase 3 trials have made major contributions to advances in prostate cancer (PCa). However, funding limitations and excess bureaucracy are now making it difficult to conduct trials.

U2 - 10.1016/j.eururo.2014.08.076

DO - 10.1016/j.eururo.2014.08.076

M3 - Review article

C2 - 25218582

SN - 1873-7560

VL - 67

SP - 904

EP - 912

JO - European Urology

JF - European Urology

IS - 5

ER -